Petrelintide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Sep 2026: Trial registered, NCT07843498
  2. 30 Sep 2026: Trial started, NCT07843498

The trials

NCT07843498: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

State
Under way
Phase
Phase 3
People
3,900 planned
Started
30 Sep 2026
Primary completion
21 Dec 2028
Arms
Petrelintide
Results
None posted
  1. 28 Sep 2026: Trial registered
  2. 30 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.